1
|
Kombe AJK, Zoa-Assoumou S, Bounda GA, Nsole-Biteghe FA, Jin T, Zouré AA. Advances in Etiopathological Role and Control of HPV in Cervical Cancer Oncogenesis. FRONT BIOSCI-LANDMRK 2023; 28:245. [PMID: 37919078 DOI: 10.31083/j.fbl2810245] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2023] [Revised: 07/13/2023] [Accepted: 07/31/2023] [Indexed: 11/04/2023]
Abstract
The human papillomavirus (HPV) is a well-known oncovirus whose causal link in the occurrence and development of several cancers, such as cervical cancer (CC), has been well established. Indeed, numerous researches depicted the etiological role of HPV in CC pathogenesis in such a way as to develop efficient strategies, including early diagnoses and HPV vaccination, to mitigate HPV infection and CC occurrence. Despite the effectiveness of these strategies in preventing HPV infection, its persistence, and the progression to precancerous lesions and cancers, extensive work that could give a better understanding of other unknown factors favoring oncogenesis is much more needed. In this last decade, scarce or few but crucial and strategic studies have been carried out to improve and deepen our understanding of the etiopathological role of HPV in the progression towards the development of CC. In this review, we highlighted the recent findings on the pathological role of HPV in CC occurrence and the advances in novel adopted strategies to reduce HPV infection and prevent CC occurrence more effectively.
Collapse
Affiliation(s)
- Arnaud John Kombe Kombe
- Department of Obstetrics and Gynecology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, 230001 Hefei, Anhui, China
| | - Samira Zoa-Assoumou
- Departement de Bacteriologie-Virologie, Université des Sciences de la Santé, BP 18231 Libreville, Gabon
| | - Guy-Armel Bounda
- Department of Clinical Pharmacy, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, 210009 Jiangsu, Nanjing, China
| | | | - Tengchuan Jin
- Department of Obstetrics and Gynecology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, 230001 Hefei, Anhui, China
- Laboratory of Structural Immunology, CAS Key Laboratory of Innate Immunity and Chronic Disease, Division of Life Sciences and Medicine, University of Science and Technology of China, 230027 Hefei, Anhui, China
- Institute of Health and Medicine, Hefei Comprehensive National Science Center, 230007 Hefei, Anhui, China
| | - Abdou Azaque Zouré
- Institut de Recherche en Science de la Santé, Centre National de Recherche Scientifique et Technologique (IRSS/CNRST), BP 7047 Ouagadougou 03, Burkina Faso
| |
Collapse
|
2
|
Mintsa-Nguema R, Zoa-Assoumou S, Mewono L, M’Bondoukwé NP, Essono P, Mengue-Me-Ngou-Milama K, Boukandou-Mounanga M, Ndong-Ngomo JM, Mintsa-Ndong A, Ngoungou EB, Bouyou-Akotet MK, Mbongo-Kama E. Could pooled samples method affect SARS-CoV-2 diagnosis accuracy using BGI and Sansure-Biotech RT-PCR kits used in Gabon, Central Africa? PLoS One 2022; 17:e0262733. [PMID: 35061822 PMCID: PMC8782308 DOI: 10.1371/journal.pone.0262733] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2021] [Accepted: 01/04/2022] [Indexed: 11/29/2022] Open
Abstract
This study aims at establishing specimens pooling approach for the detection of SARS-CoV-2 using the RT-PCR BGI and Sansure-Biotech kits used in Gabon. To validate this approach, 14 positive samples, stored at -20°C for three to five weeks were analyzed individually (as gold standard) and in pools of five, eight and ten in the same plate. We created 14 pools of 5, 8 and 10 samples using 40 μL from each of the selected positive samples mixed with 4, 7 and 9 confirmed negative counterparts in a total volume of 200 μL, 320 μL and 400 μL for the pools of 5, 8 and 10 respectively. Both individual and pooled samples testing was conducted according to the BGI and Sansure-Biotech RT-PCR protocols used at the Professor Daniel Gahouma Laboratory (PDGL). Furthermore, the pooling method was also tested by comparing results of 470 unselected samples tested in 94 pools and individually. Results of our experiment showed that using a BGI single positive sample with cycle threshold (Ct) value of 28.42, confirmed by individual testing, detection occurred in all the pools. On the contrary samples with Ct >31 were not detected in pools of 10 and for these samples (Ct value as high as 37.17) their detection was possible in pool of 8. Regarding the Sansure-Biotech kit, positive samples were detected in all the pool sizes tested, irrespective of their Ct values. The specificity of the pooling method was 100% for the BGI and Sansure-Biotech RT-PCR assays. The present study found an increase in the Ct values with pool size for the BGI and Sansure-Biotech assays. This trend was statistically significant (Pearson’s r = 0.978; p = 0,022) using the BGI method where the mean Ct values were 24.04±1.1, 26.74±1.3, 27.91±1.1 and 28.32±1.1 for the individual, pool of 5, 8 and 10 respectively. The testing of the 470 samples showed that one of the 94 pools had a positive test similar to the individual test using the BGI and Sansure-Biotech kits. The saving of time and economizing test reagents by using the pooling method were demonstrated in this study. Ultimately, the pooling method could be used for the diagnosis of SARS-CoV-2 without modifying the accuracy of results in Gabon. We recommend a maximum pool size of 8 for the BGI kit. For the Sansure-Biotech kit, a maximum pool size of 10 can be used without affecting its accuracy compared to the individual testing.
Collapse
Affiliation(s)
- Rodrigue Mintsa-Nguema
- Research Institute in Tropical Ecology, National Center for Scientific and Technological Research, Libreville, Gabon
- Professor Daniel Gahouma Laboratory, Ministry of Health, Libreville, Gabon
- * E-mail:
| | - Samira Zoa-Assoumou
- Professor Daniel Gahouma Laboratory, Ministry of Health, Libreville, Gabon
- Department of Bacteriology-Virology, University of Health Science, Libreville, Gabon
| | - Ludovic Mewono
- Professor Daniel Gahouma Laboratory, Ministry of Health, Libreville, Gabon
- Department of Biology, Higher Normal School, Libreville, Gabon
| | - Noé P. M’Bondoukwé
- Professor Daniel Gahouma Laboratory, Ministry of Health, Libreville, Gabon
- Department of Parasitology-Mycology, University of Health Science, Libreville, Gabon
| | - Paulin Essono
- Professor Daniel Gahouma Laboratory, Ministry of Health, Libreville, Gabon
- National Laboratory of Public Health, Libreville, Gabon
| | - Krystina Mengue-Me-Ngou-Milama
- Professor Daniel Gahouma Laboratory, Ministry of Health, Libreville, Gabon
- National Laboratory of Public Health, Libreville, Gabon
| | - Marlaine Boukandou-Mounanga
- Professor Daniel Gahouma Laboratory, Ministry of Health, Libreville, Gabon
- Institute of Pharmacopeia and Traditional Medicine, National Center for Scientific and Technological Research, Libreville, Gabon
| | - Jacques M. Ndong-Ngomo
- Professor Daniel Gahouma Laboratory, Ministry of Health, Libreville, Gabon
- Department of Parasitology-Mycology, University of Health Science, Libreville, Gabon
| | | | - Edgard B. Ngoungou
- Department of Parasitology-Mycology, University of Health Science, Libreville, Gabon
| | | | - Elvyre Mbongo-Kama
- Professor Daniel Gahouma Laboratory, Ministry of Health, Libreville, Gabon
| |
Collapse
|
3
|
Abe H, Ushijima Y, Bikangui R, Zoa-Assoumou S, Ondo GN, Manouana GP, More A, Skarwan E, Yali-Assy-Oyamli Y, Ndeboko B, Myrabelle Avome Houechenou R, Djoba Siawaya JF, Lell B, Adegnika AA, Yasuda J. Unrecognized introduction of SARS-CoV-2 variants of concern to Central Africa: Import and local transmission of B.1.1.7 in Gabon in the very early stage of the variant spread to the African continent. J Med Virol 2021; 93:6054-6058. [PMID: 34185327 PMCID: PMC8426813 DOI: 10.1002/jmv.27164] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2021] [Accepted: 06/25/2021] [Indexed: 11/16/2022]
Abstract
The rapid spread of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) variant of concern with higher infectivity has already resulted in the enormous increase in infection cases worldwide. We report an unrecognized introduction of the variant B.1.1.7 in Gabon in December 2020, which was the initial phase of the variant introduction to Africa. The B.1.1.7 variant was also detected in a hospitalized patient in January 2021, indicating a rapid spread of the variant in Gabon since its first detection. Phylogenetic analysis revealed that the detected B.1.1.7 variants originated from the distinct regions, strongly suggesting that the B.1.1.7 variant had been repeatedly introduced to Gabon since December 2020. These results provide insights on the unrecognized risks of infections with variants of concern, and show the necessity to conduct continuous genomic monitoring for immediate alert and control of novel SARS‐CoV‐2 variant infections.
Collapse
Affiliation(s)
- Haruka Abe
- Department of Emerging Infectious Diseases, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan
| | - Yuri Ushijima
- Department of Emerging Infectious Diseases, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan
| | | | - Samira Zoa-Assoumou
- Université des Sciences de la Santé, Libreville, Gabon.,Laboratoire Professeur Daniel GAHOUMA, Libreville, Gabon
| | | | | | - Ayong More
- Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon
| | - Emilio Skarwan
- Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon
| | | | - Bénédicte Ndeboko
- Université des Sciences de la Santé, Libreville, Gabon.,Centre Hospitalier Universitaire Mère-enfant Fondation Jeanne EBORI, Libreville, Gabon
| | | | | | - Bertrand Lell
- Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.,Division of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Vienna, Austria
| | - Ayola Akim Adegnika
- Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.,Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany.,German Center for Infection Research, Tübingen, Germany
| | - Jiro Yasuda
- Department of Emerging Infectious Diseases, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.,National Research Center for the Control and Prevention of Infectious Diseases (CCPID), Nagasaki University, Nagasaki, Japan
| |
Collapse
|
4
|
Zoa-Assoumou S, Ndeboko B, Manouana GP, Houechenou RMA, Bikangui R, Mveang-Nzoghe A, Ondo GN, Mbongo-Kama E, Lell B, Abe H, Ushijima Y, Antchouey AM, Yasuda J, Adegnika AA, Siawaya JFD. SARS-CoV-2 emerging variants in Africa: view from Gabon. Lancet Microbe 2021; 2:e349. [PMID: 34124702 PMCID: PMC8186850 DOI: 10.1016/s2666-5247(21)00125-7] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Affiliation(s)
- Samira Zoa-Assoumou
- Département de Bactériologie-Virologie, Université des Sciences de la Santé, Libreville, Gabon.,Laboratoire Professeur Daniel Gahouma, Libreville, Gabon
| | - Bénédicte Ndeboko
- Département de Biologie Cellulaire et Biologie Moléculaire, Université des Sciences de la Santé, Libreville, Gabon.,Centre Hospitalier Universitaire Mère-Enfant Fondation Jeanne Ebori, Libreville, Gabon
| | - Gédéon Prince Manouana
- Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany.,Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon
| | | | | | | | | | | | - Bertrand Lell
- Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.,Medical University of Vienna, Vienna, Austria
| | - Haruka Abe
- Department of Emerging Infectious Diseases, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan
| | - Yuri Ushijima
- Department of Emerging Infectious Diseases, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan
| | | | - Jiro Yasuda
- Department of Emerging Infectious Diseases, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan
| | - Ayola Akim Adegnika
- Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany.,Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.,German Center for Infection Research, Tübingen, Germany
| | | |
Collapse
|
5
|
Bivigou-Mboumba B, Amougou-Atsama M, Zoa-Assoumou S, M’boyis Kamdem H, Nzengui-Nzengui GF, Ndojyi-Mbiguino A, Njouom R, François-Souquière S. Hepatitis B infection among HIV infected individuals in Gabon: Occult hepatitis B enhances HBV DNA prevalence. PLoS One 2018; 13:e0190592. [PMID: 29315352 PMCID: PMC5760027 DOI: 10.1371/journal.pone.0190592] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2017] [Accepted: 12/17/2017] [Indexed: 12/15/2022] Open
Abstract
In Gabon, a central African country, human immunodeficiency virus (HIV) and hepatitis B virus (HBV) are endemic. In a recent study, conducted in a semi-urban area (Franceville, Gabon), HBV infection was found to be more prevalent among HIV infected individuals. This study aims to investigate the prevalence and genetic diversity of hepatitis B virus infection among HIV infected individuals, predominantly under antiretroviral therapy, living in fully urbanized area: Libreville, capital of Gabon. Serological and molecular tests were performed to detect HBV infection among patients living with HIV/AIDS (PLHA). We used Monolisa HBsAg ULTRA, Anti-HBc Plus and Anti-HBs Plus EIA kits for serological analyses. HBV DNA viral load (HBV DNA VL) was determined by real time PCR and molecular characterization of HBV strains was performed by sequencing and phylogenetic analysis of partial HBV surface and core genes. At all, 70.2% of patients were under antiretroviral therapy. The prevalence of HBsAg was 8.8% (43/487). Detectable HBV DNA was found in 69.7% (30/43) of HBsAg positive patients and in 17.5% (24/137) HBsAg negative patients. HBV DNA VL was significantly higher among patient with CD4 cell counts less than 200 cells/mm3 than those with CD4 cell counts greater than 500 cells/mm3 (p = 0.008). We confirmed the presence of HBV sub-genotypes QS-A3 (40%), and A4 (20%) and HBV-E genotype (40%). The percentage of resistance to Lamivudine was high (40%) and varied according to the M204V/I motif. Occult hepatitis B infection (OBI) was found in patients with isolated HBcAb and among patients who had completed their HBsAg seroconversion. We detected HBV DNA for one patient without any HBV serological marker. This study provides a new landmark for the comprehension of HBV infection in PLHA in urban areas. OBI enhances HBV DNA prevalence and should be investigated in all HBsAg negative individuals.
Collapse
Affiliation(s)
- Berthold Bivigou-Mboumba
- Unité Mixte de Recherches VIH et Maladies Infectieuses Associées (UMR VIH-MIA), Centre International de Recherches Médicales (CIRMF), Libreville, Gabon
- Laboratoire de Bactériologie-Virologie, Laboratoire de Référence IST-SIDA, Université des Sciences de la Santé, Owendo, Gabon
- * E-mail:
| | | | - Samira Zoa-Assoumou
- Laboratoire de Bactériologie-Virologie, Laboratoire de Référence IST-SIDA, Université des Sciences de la Santé, Owendo, Gabon
| | - Hervé M’boyis Kamdem
- Laboratoire de Bactériologie-Virologie, Laboratoire de Référence IST-SIDA, Université des Sciences de la Santé, Owendo, Gabon
| | - Guy Francis Nzengui-Nzengui
- Laboratoire de Bactériologie-Virologie, Laboratoire de Référence IST-SIDA, Université des Sciences de la Santé, Owendo, Gabon
| | - Angélique Ndojyi-Mbiguino
- Laboratoire de Bactériologie-Virologie, Laboratoire de Référence IST-SIDA, Université des Sciences de la Santé, Owendo, Gabon
| | - Richard Njouom
- Service de Virologie, Centre Pasteur du Cameroun, Yaoundé, Cameroun
| | - Sandrine François-Souquière
- Unité Mixte de Recherches VIH et Maladies Infectieuses Associées (UMR VIH-MIA), Centre International de Recherches Médicales (CIRMF), Libreville, Gabon
- Laboratoire de Bactériologie-Virologie, Laboratoire de Référence IST-SIDA, Université des Sciences de la Santé, Owendo, Gabon
| |
Collapse
|
6
|
Zoa-Assoumou S, Ndjoyi-Mbiguino A, Mabika BM, Belembaogo E, Khattabi A, Ennaji MM. Human papillomavirus genotypes distribution in cervical cancer cases in Gabon. Infect Agent Cancer 2016; 11:42. [PMID: 27532014 PMCID: PMC4986226 DOI: 10.1186/s13027-016-0091-8] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2016] [Accepted: 06/28/2016] [Indexed: 02/05/2023] Open
Abstract
Background Cervical cancer is a real public health problem in African countries. The relation between HPV and cervical cancer is well established. However, it is known that the distribution of HPV genotypes differ geographically and this may influence the effectiveness of the three available vaccines, which among other HPV genotypes targets the genotypes 16 and 18 that cause about 70 % of cervical cancers cases. The objective of this study was to identify for the first time the HPV genotypes distribution in cervical cancer specimens obtained from Gabonese women. Methods A total of 105 cervical samples including 93 formalin-fixed paraffin embedded tissues collected between 2007 and 2013 and 12 fresh biopsies collected in August 2013 were investigated. The presence of HPV DNA was analyzed by nested PCR with primers MY09/11 and GP5+/6+ followed by sequencing for HPV genotyping. Results Amplification of the housekeeping gene (β-globin) with PCO4/GH20 primers was successful for 91.4 % (96/105) of the cervical cancer samples and HPV DNA was detected in all the 96 samples. Five different HPV genotypes were identified. HPV 16 [58.3 %; 95 % IC: 48.44–68.16] was the most common genotype followed by HPV 33 [25.0 %; 95 % IC: 16.34–33.66], HPV 18 [8.4 %; 95 % IC: 2.86–13.94], HPV 70 [7.3 %; 95 % IC: 2.1–12.5] and HPV 31 [1.1 %; 95 % IC: −0.986–3.186]. HPV 16 was also the most prevalent in all histological malignant lesions. It was found in 56.6 % of squamous cervical carcinoma and 69.2 % of adenocarcinoma. Concerning the HPV positive adenocarcinoma cases, HPV 18 was identified in 7.7 % (1/13). Conclusion These findings show the predominance of HPV 16 in cervical cancer cases among Gabonese women. However, HPV33 is more prevalent than HPV18. Our study suggests that HPV vaccines may be effective at reducing the burden of cervical cancer in Gabon.
Collapse
Affiliation(s)
- Samira Zoa-Assoumou
- Laboratoire National de Référence IST/Sida, Laboratoire de Référence OMS Rougeole, Rubéole, Fièvre jaune et Tétanos néonatal, Département de Bactériologie-Virologie, Faculté de Médecine et des Sciences de la Santé, Université des Sciences de la Santé, Libreville, Gabon ; Laboratoire de Virologie, Microbiologie et Qualité/Eco-toxicologie et Biodiversité, Faculté des Sciences et Techniques de Mohammedia, Université Hassan II-Casablanca, Casablanca, Morocco
| | - Angelique Ndjoyi-Mbiguino
- Laboratoire National de Référence IST/Sida, Laboratoire de Référence OMS Rougeole, Rubéole, Fièvre jaune et Tétanos néonatal, Département de Bactériologie-Virologie, Faculté de Médecine et des Sciences de la Santé, Université des Sciences de la Santé, Libreville, Gabon
| | - Barthelemy Mabika Mabika
- Département d'Anatomie et de Cytologie pathologiques, Faculté de Médecine et des Sciences de la Santé, Université des Sciences de la Santé, Libreville, Gabon
| | | | - Abdelkim Khattabi
- Laboratoire d'Agroalimentaire et Santé, Département de biologie, Faculté des Sciences et Techniques de Settat, Université Hassan I, Settat, Morocco
| | - My Mustapha Ennaji
- Laboratoire de Virologie, Microbiologie et Qualité/Eco-toxicologie et Biodiversité, Faculté des Sciences et Techniques de Mohammedia, Université Hassan II-Casablanca, Casablanca, Morocco
| |
Collapse
|